Search research articles
Contact Us
Filters
Showing results (171-180 of 510) with videos related to
Page
of 51
Sort By:
Pacing and Clinical Electrophysiology : PACE
|
August 21, 2014
The healthcare utilization and cost of treating patients experiencing inappropriate implantable cardioverter defibrillator shocks: a propensity score study
Sanjeev P Bhavnani, Dalia Giedrimiene, Craig I Coleman, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
April 3, 2023
Effectiveness and Safety of Rivaroxaban Versus Warfarin among Nonvalvular Atrial Fibrillation Patients with Concomitant Obstructive Sleep Apnea
Nitesh Sood, Veronica Ashton, Youssef Bessada, et al.
Journal of Dietary Supplements
|
March 23, 2012
Feverfew for migraine prophylaxis: a systematic review
Elisa Saranitzky, C Michael White, Erica L Baker, et al.
Hospital Practice (1995)
|
May 17, 2016
Outcomes related to variation in hospital pulmonary embolus observation stay utilization
Craig I Coleman, W Frank Peacock, Erin R Weeda, et al.
JAMA
|
January 5, 2006
Statins and cancer risk: a meta-analysis
Krista M Dale, Craig I Coleman, Nickole N Henyan, et al.
BMJ Open
|
October 30, 2015
Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database
Craig I Coleman, Christine G Kohn, Concetta Crivera, et al.
Bjpsych Open
|
October 7, 2022
Risk factor profiles for depression following childbirth or a chronic disease diagnosis: case-control study
Bradley S Jermy, Saskia Hagenaars, Jonathan R I Coleman, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 29, 2012
Cost-effectiveness of apixaban compared with aspirin for stroke prevention in atrial fibrillation among patients unsuitable for warfarin
Soyon Lee, Moise W Anglade, Joy Meng, et al.
Thrombosis and Haemostasis
|
March 23, 2018
Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban
A John Camm, Craig I Coleman, Torben Bjerregaard Larsen, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
May 8, 2009
Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis
Deborah A Cios, William L Baker, Stephen D Sander, et al.
Page
of 51
Search research articles
Search
Showing results (171-180 of 510) with videos related to
Sort By:
Page
of 51
Pacing and Clinical Electrophysiology : PACE
|
August 21, 2014
The healthcare utilization and cost of treating patients experiencing inappropriate implantable cardioverter defibrillator shocks: a propensity score study
Sanjeev P Bhavnani, Dalia Giedrimiene, Craig I Coleman, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
April 3, 2023
Effectiveness and Safety of Rivaroxaban Versus Warfarin among Nonvalvular Atrial Fibrillation Patients with Concomitant Obstructive Sleep Apnea
Nitesh Sood, Veronica Ashton, Youssef Bessada, et al.
Journal of Dietary Supplements
|
March 23, 2012
Feverfew for migraine prophylaxis: a systematic review
Elisa Saranitzky, C Michael White, Erica L Baker, et al.
Hospital Practice (1995)
|
May 17, 2016
Outcomes related to variation in hospital pulmonary embolus observation stay utilization
Craig I Coleman, W Frank Peacock, Erin R Weeda, et al.
JAMA
|
January 5, 2006
Statins and cancer risk: a meta-analysis
Krista M Dale, Craig I Coleman, Nickole N Henyan, et al.
BMJ Open
|
October 30, 2015
Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database
Craig I Coleman, Christine G Kohn, Concetta Crivera, et al.
Bjpsych Open
|
October 7, 2022
Risk factor profiles for depression following childbirth or a chronic disease diagnosis: case-control study
Bradley S Jermy, Saskia Hagenaars, Jonathan R I Coleman, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 29, 2012
Cost-effectiveness of apixaban compared with aspirin for stroke prevention in atrial fibrillation among patients unsuitable for warfarin
Soyon Lee, Moise W Anglade, Joy Meng, et al.
Thrombosis and Haemostasis
|
March 23, 2018
Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban
A John Camm, Craig I Coleman, Torben Bjerregaard Larsen, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
May 8, 2009
Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis
Deborah A Cios, William L Baker, Stephen D Sander, et al.
Page
of 51